STOCK TITAN

[Form 4] Corvel Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Michael Jeffrey J, identified as a director and 10% owner of CorVel Corp (CRVL), was granted 1,500 non-qualified stock options on 08/07/2025 with an exercise price of $85.56. The options expire on 08/07/2035 and become exercisable in four equal annual installments beginning 12 months after the grant, so vesting begins on 08/07/2026. The Form 4 reports the reporting person directly beneficially owns 1,500 derivative securities following the transaction. The filing is signed on 08/11/2025.

Michael Jeffrey J, identificato come direttore e titolare del 10% di CorVel Corp (CRVL), ha ricevuto in data 08/07/2025 la concessione di 1.500 opzioni su azioni non qualificate con un prezzo di esercizio di $85.56. Le opzioni scadono il 08/07/2035 e diventano esercitabili in quattro tranche annuali uguali a partire 12 mesi dalla concessione, quindi la maturazione inizia il 08/07/2026. Il Modulo 4 segnala che la persona comunicante detiene direttamente, a titolo beneficiario, 1.500 titoli derivati a seguito della transazione. Il documento è firmato il 08/11/2025.

Michael Jeffrey J, identificado como director y propietario del 10% de CorVel Corp (CRVL), recibió el 08/07/2025 la concesión de 1.500 opciones sobre acciones no calificadas con un precio de ejercicio de $85.56. Las opciones vencen el 08/07/2035 y se vuelven ejercitables en cuatro cuotas anuales iguales a partir de 12 meses tras la concesión, por lo que la adquisición de derechos comienza el 08/07/2026. El Formulario 4 indica que la persona informante posee directamente, con carácter beneficiario, 1.500 valores derivados tras la operación. La presentación está firmada el 08/11/2025.

Michael Jeffrey J는 CorVel Corp (CRVL)의 이사이자 10% 지분 보유자로 확인되었으며, 08/07/2025에 행사 가격 $85.561,500 비적격 주식옵션을 부여받았습니다. 이 옵션들은 08/07/2035에 만료되며 부여일로부터 12개월 후부터 4년간 매년 동일한 비율로 나누어 행사 가능해져, 베스팅은 08/07/2026에 시작됩니다. Form 4에는 거래 후 보고인이 직접적으로 1,500개의 파생증권을 실질적으로 보유하고 있는 것으로 기재되어 있습니다. 제출 서류는 08/11/2025에 서명되었습니다.

Michael Jeffrey J, identifié comme administrateur et propriétaire de 10% de CorVel Corp (CRVL), s'est vu accorder le 08/07/2025 1 500 options sur actions non qualifiées au prix d'exercice de $85.56. Les options expirent le 08/07/2035 et deviennent exerçables en quatre versements annuels égaux à compter de 12 mois après l'attribution, de sorte que la période d'acquisition commence le 08/07/2026. Le Formulaire 4 indique que le déclarant détient directement, à titre bénéficiaire, 1 500 titres dérivés à la suite de la transaction. Le dépôt est signé le 08/11/2025.

Michael Jeffrey J, als Direktor und 10%-Eigentümer von CorVel Corp (CRVL) ausgewiesen, erhielt am 08/07/2025 1.500 nicht qualifizierte Aktienoptionen mit einem Ausübungspreis von $85.56. Die Optionen laufen am 08/07/2035 ab und werden in vier gleichen jährlichen Raten ausübbar, beginnend 12 Monate nach der Gewährung; die Vesting-Periode beginnt somit am 08/07/2026. Formular 4 berichtet, dass die meldende Person infolge der Transaktion direkt wirtschaftlich an 1.500 derivativen Wertpapieren beteiligt ist. Die Einreichung ist datiert und unterzeichnet am 08/11/2025.

Positive
  • 1,500 non-qualified stock options granted to a director and 10% owner on 08/07/2025
  • Clear vesting schedule: four equal annual installments commencing 12 months after grant; 10-year term to 08/07/2035
Negative
  • None.

Insights

TL;DR: Routine director option grant: 1,500 options, $85.56 strike, 4-year vesting, 10-year term.

This Form 4 documents a standard non-qualified stock option grant to a director who is also a 10% owner. Key facts are the 1,500-option size, $85.56 exercise price, vesting in four equal annual installments starting 12 months after grant, and a 10-year expiration to 08/07/2035. The filing shows direct beneficial ownership of the 1,500 options following the grant. From a governance perspective, the disclosure is clear and follows required Section 16 reporting rules.

TL;DR: Typical equity-based compensation structure with multi-year vesting and long exercise window; no other compensation detail disclosed.

The grant is a non-qualified stock option with an explicit exercise price of $85.56 and a stated vesting schedule of four equal annual installments beginning 12 months post-grant. The instrument covers 1,500 shares and expires on 08/07/2035. The Form 4 does not provide additional compensation terms (such as performance conditions or forfeiture provisions), so assessment is limited to the shown mechanics of the award.

Michael Jeffrey J, identificato come direttore e titolare del 10% di CorVel Corp (CRVL), ha ricevuto in data 08/07/2025 la concessione di 1.500 opzioni su azioni non qualificate con un prezzo di esercizio di $85.56. Le opzioni scadono il 08/07/2035 e diventano esercitabili in quattro tranche annuali uguali a partire 12 mesi dalla concessione, quindi la maturazione inizia il 08/07/2026. Il Modulo 4 segnala che la persona comunicante detiene direttamente, a titolo beneficiario, 1.500 titoli derivati a seguito della transazione. Il documento è firmato il 08/11/2025.

Michael Jeffrey J, identificado como director y propietario del 10% de CorVel Corp (CRVL), recibió el 08/07/2025 la concesión de 1.500 opciones sobre acciones no calificadas con un precio de ejercicio de $85.56. Las opciones vencen el 08/07/2035 y se vuelven ejercitables en cuatro cuotas anuales iguales a partir de 12 meses tras la concesión, por lo que la adquisición de derechos comienza el 08/07/2026. El Formulario 4 indica que la persona informante posee directamente, con carácter beneficiario, 1.500 valores derivados tras la operación. La presentación está firmada el 08/11/2025.

Michael Jeffrey J는 CorVel Corp (CRVL)의 이사이자 10% 지분 보유자로 확인되었으며, 08/07/2025에 행사 가격 $85.561,500 비적격 주식옵션을 부여받았습니다. 이 옵션들은 08/07/2035에 만료되며 부여일로부터 12개월 후부터 4년간 매년 동일한 비율로 나누어 행사 가능해져, 베스팅은 08/07/2026에 시작됩니다. Form 4에는 거래 후 보고인이 직접적으로 1,500개의 파생증권을 실질적으로 보유하고 있는 것으로 기재되어 있습니다. 제출 서류는 08/11/2025에 서명되었습니다.

Michael Jeffrey J, identifié comme administrateur et propriétaire de 10% de CorVel Corp (CRVL), s'est vu accorder le 08/07/2025 1 500 options sur actions non qualifiées au prix d'exercice de $85.56. Les options expirent le 08/07/2035 et deviennent exerçables en quatre versements annuels égaux à compter de 12 mois après l'attribution, de sorte que la période d'acquisition commence le 08/07/2026. Le Formulaire 4 indique que le déclarant détient directement, à titre bénéficiaire, 1 500 titres dérivés à la suite de la transaction. Le dépôt est signé le 08/11/2025.

Michael Jeffrey J, als Direktor und 10%-Eigentümer von CorVel Corp (CRVL) ausgewiesen, erhielt am 08/07/2025 1.500 nicht qualifizierte Aktienoptionen mit einem Ausübungspreis von $85.56. Die Optionen laufen am 08/07/2035 ab und werden in vier gleichen jährlichen Raten ausübbar, beginnend 12 Monate nach der Gewährung; die Vesting-Periode beginnt somit am 08/07/2026. Formular 4 berichtet, dass die meldende Person infolge der Transaktion direkt wirtschaftlich an 1.500 derivativen Wertpapieren beteiligt ist. Die Einreichung ist datiert und unterzeichnet am 08/11/2025.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MICHAEL JEFFREY J

(Last) (First) (Middle)
5128 APACHE PLUME ROAD, SUITE 400

(Street)
FORT WORTH TX 75109

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CORVEL CORP [ CRVL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $85.56 08/07/2025 A 1,500 (1) 08/07/2035 Common Stock 1,500 $0.0 1,500 D
Explanation of Responses:
1. Exercisable in a series of 4 equal and successive annual installments commencing 12 months following the date of grant.
By: Sharon O'Connor For: Jeffrey Michael 08/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Corvel Corp

NASDAQ:CRVL

CRVL Rankings

CRVL Latest News

CRVL Latest SEC Filings

CRVL Stock Data

4.61B
28.75M
43.86%
53.98%
1.55%
Insurance Brokers
Insurance Agents, Brokers & Service
Link
United States
IRVINE